Cyberfriends: The help you're looking for is probably here.
Welcome to Ed's Pathology Notes, placed here originally for the convenience of medical students at my school. You need to check the accuracy of any information, from any source, against other credible sources. I cannot diagnose or treat over the web, I cannot comment on the health care you have already received, and these notes cannot substitute for your own doctor's care. I am good at helping people find resources and answers. If you need me, send me an E-mail at scalpel_blade@yahoo.com Your confidentiality is completely respected.
DoctorGeorge.com is a larger, full-time service. There is also a fee site at myphysicians.com, and another at www.afraidtoask.com.
Translate this page automatically
With one of four large boxes of "Pathguy" replies. |
I'm still doing my best to answer everybody. Sometimes I get backlogged, sometimes my E-mail crashes, and sometimes my literature search software crashes. If you've not heard from me in a week, post me again. I send my most challenging questions to the medical student pathology interest group, minus the name, but with your E-mail where you can receive a reply.
Numbers in {curly braces} are from the magnificent Slice of Life videodisk. No medical student should be without access to this wonderful resource. Someday you may be able to access these pictures directly from this page.
I am presently adding clickable links to
images in these notes. Let me know about good online
sources in addition to these:
Also:
Medmark Pathology -- massive listing of pathology sites
Freely have you received, freely give. -- Matthew 10:8. My
site receiver(an enormous amount of traffic, and I'm
handling about 200 requests for information weekly, all
as a public service.
Pathology's modern founder,
Rudolf
Virchow M.D., left a legacy
of realism and social conscience for the discipline. I am
a mainstream Christian, a man of science, and a proponent of
common sense and common kindness. I am an outspoken enemy
of all the make-believe and bunk that interfere with
peoples' health, reasonable freedom, and happiness. I
talk and write straight, and without apology.
Throughout these notes, I am speaking only
for myself, and not for any employer, organization,
or associate.
Special thanks to my friend and colleague,
Charles Wheeler M.D.,
pathologist and former Kansas City mayor. Thanks also
to the real Patch
Adams M.D., who wrote me encouragement when we were both
beginning our unusual medical careers.
If you're a private individual who's
enjoyed this site, and want to say, "Thank you, Ed!", then
what I'd like best is a contribution to the Episcopalian home for
abandoned, neglected, and abused kids in Nevada:
My home page
Especially if you're looking for
information on a disease with a name
that you know, here are a couple of
great places for you to go right now
and use Medline, which will
allow you to find every relevant
current scientific publication.
You owe it to yourself to learn to
use this invaluable internet resource.
Not only will you find some information
immediately, but you'll have references
to journal articles that you can obtain
by interlibrary loan, plus the names of
the world's foremost experts and their
institutions.
Alternative (complementary) medicine has made real progress since my
generally-unfavorable 1983 review linked below. If you are
interested in complementary medicine, then I would urge you
to visit my new
Alternative Medicine page.
If you are looking for something on complementary
medicine, please go first to
the American
Association of Naturopathic Physicians.
And for your enjoyment... here are some of my old pathology
exams
for medical school undergraduates.
I cannot examine every claim that my correspondents
share with me. Sometimes the independent thinkers
prove to be correct, and paradigms shift as a result.
You also know that extraordinary claims require
extraordinary evidence. When a discovery proves to
square with the observable world, scientists make
reputations by confirming it, and corporations
are soon making profits from it. When a
decades-old claim by a "persecuted genius"
finds no acceptance from mainstream science,
it probably failed some basic experimental tests designed
to eliminate self-deception. If you ask me about
something like this, I will simply invite you to
do some tests yourself, perhaps as a high-school
science project. Who knows? Perhaps
it'll be you who makes the next great discovery!
Our world is full of people who have found peace, fulfillment, and friendship
by suspending their own reasoning and
simply accepting a single authority that seems wise and good.
I've learned that they leave the movements when, and only when, they
discover they have been maliciously deceived.
In the meantime, nothing that I can say or do will
convince such people that I am a decent human being. I no longer
answer my crank mail.
This site is my hobby, and I presently have no sponsor.
This page was last updated February 6, 2006.
During the ten years my site has been online, it's proved to be
one of the most popular of all internet sites for undergraduate
physician and allied-health education. It is so well-known
that I'm not worried about borrowers.
I never refuse requests from colleagues for permission to
adapt or duplicate it for their own courses... and many do.
So, fellow-teachers,
help yourselves. Don't sell it for a profit, don't use it for a bad purpose,
and at some time in your course, mention me as author and KCUMB as my institution. Drop me a note about
your successes. And special
thanks to everyone who's helped and encouraged me, and especially the
people at KCUMB
for making it possible, and my teaching assistants over the years.
Whatever you're looking for on the web, I hope you find it,
here or elsewhere. Health and friendship!
Pathology Education Instructional Resource -- U. of Alabama; includes a digital library
Houston Pathology -- loads of great pictures for student doctors
Pathopic -- Swiss site; great resource for the truly hard-core
Syracuse -- pathology cases
Walter Reed -- surgical cases
Alabama's Interactive Pathology Lab
"Companion to Big Robbins" -- very little here yet
Alberta
Pathology Images --hard-core!
Cornell
Image Collection -- great site
Bristol Biomedical
Image Archive
EMBBS Clinical
Photo Library
Chilean Image Bank -- General Pathology -- en Español
Chilean Image Bank -- Systemic Pathology -- en Español
Connecticut
Virtual Pathology Museum
Australian
Interactive Pathology Museum
Semmelweis U.,
Budapest -- enormous pathology photo collection
Iowa Skin
Pathology
Loyola
Dermatology
History of Medicine -- National Library of Medicine
KU
Pathology Home
Page -- friends of mine
The Medical Algorithms Project -- not so much pathology, but worth a visit
National Museum of Health & Medicine -- Armed Forces Institute of Pathology
Telmeds -- brilliant site by the medical students of Panama (Spanish language)
U of
Iowa Dermatology Images
U Wash
Cytogenetics Image Gallery
Urbana
Atlas of Pathology -- great site
Visible
Human Project at NLM
WebPath:
Internet Pathology
Laboratory -- great siteEd Lulo's Pathology Gallery
Bryan Lee's Pathology Museum
Dino Laporte: Pathology Museum
Tom Demark: Pathology Museum
Dan Hammoudi's Site
Claude Roofian's Site
Pathology Handout -- Korean student-generated site; I am pleased to permit their use of my cartoons
Estimating the Time of Death -- computer program right on a webpage
Pathology Field Guide -- recognizing anatomic lesions, no pictures
St.
Jude's Ranch for Children
I've spent time there and they are good. Write "Thanks
Ed" on your check.
PO Box 60100
Boulder City, NV 89006--0100
More of my notes
My medical students
Clinical
Queries -- PubMed from the National Institutes of Health.
Take your questions here first.
HealthWorld
Yahoo! Medline lists other sites that may work well for you
We comply with the
HONcode standard for health trust worthy
information:
verify
here.
Describe some theoretical mechanisms of autoimmune disease. Give examples of known or suspected triggers for autoimmune disease.
List the common autoimmune diseases -- both those included in this lecture, and related disorders.
Give the predisposing factors, typical symptoms, signs, laboratory findings (especially autoantibodies), and pathologic anatomy for each of the following:
systemic lupus
discoid lupus
drug induced lupus
Sjogren's syndrome
progressive systemic sclerosis (scleroderma)
polymyositis-dermatomyositis
fibromyalgia syndrome ("fibrositis" -- not an autoimmune disease)
graft vs. host disease
Give the distinguishing features for each of the following:
CREST syndrome (anti-centromere disease)
mixed connective tissue disease (anti-ribonucleoprotein disease)
Recognize the following using the microscope:
acanthosis
parakeratosis
keratin plugs
hydropic change of basal cells
lupus dermal inflammatory infiltrate
Sjogren's changes in salivary gland
scleroderma skin changes
intimal proliferation ("onion-skinning") in the renal arteries
rheumatoid nodule (characteristic features)
polymyositis
Recognize lupus as today's "great imposter", and keep a high index of suspicion for all the common autoimmune diseases.
INTRODUCTION TO AUTOIMMUNE DISEASE
Autoimmune disease in humans can involve any of the types of "immunologic injury". (Type I injury is rare.)
The mechanisms of autoimmunity remain speculative, despite the elaborate discussion in "Big Robbins". Review: Nat. Med. 7: 899, 2001. Yet another: Nat. Med. 8: 899, 2002. To begin with, nobody really understands why our immune system doesn't attack ourselves more often. You'll hear about clonal deletion, clonal anergy, and suppression of autoreactive clones (by such things as anti-idiotype networks, etc.)
Whatever the "cause" of autoimmunity, infectious agents may be involved as triggers. For example:
Coxsackie B virus apparently shares an antigen with myocardium, and infection with this virus can trigger a lethal myocarditis ("Barney Clark's disease", etc.)
Measles virus shares an antigen with T-cells, and people with measles have greatly diminished T-cell function (anergy).
The Lyme bacillus flagellum protein ("flagellin") is a mimic for axon protein, and one of the most dread effects of Lyme infection is toxicity to the nerves; despite a decade of discussion, whether this is clinically important remains unsettled (Infect. Immun. 65: 1722, 1997). An outer surface protein is a mimic for one of the HLA types that, when present, results in Lyme patients developing an arthritis that does not resolve after the micro-organisms are killed (J. Immuno. 166: 5286, 2001).
Beta-hemolytic streptococci share an antigen with myocardium (causes the myocarditis of rheumatic fever) and basal ganglia ("St. Vitus Dance", "Sydenham's chorea", PANDAS -- "pediatric acquired neurotic disorder after strep").
* During the 1990's, several gram-negative bacilli were "usual suspects" in autoimmune disease. Again, the area's hard to study; the one link that seems to be holding up is klebsiella and ankylosing spondylitis. The molecular biology of gram-negative bacterial-induced molecular mimicry: Nat. Med. 6: 215, 2000.
* Molecular mimicry probably causes the production of the autoantibodies that cause Guillain-Barre syndrome (Neurology 54: 1453, 2000; Lancet 352: 635, 1998; Neurology 57: 736, 2001).
* Molecular mimicry is the cause of post-herpes corneal interstitial inflammation in mice (Science 279: 1344, 1998).
* Beçet's (aphthous-style ulcers in the mouth, maybe genitals, elsewhere, plus maybe vasculitis-thrombosis, plus maybe iridocyclitis) seems to be caused by T-cell autoimmunity / molecular mimicry against the heat-shock proteins (Lancet 347: 789, 1996; Lancet 350: 28, 1997).
AIDS virus infection can simulate (trigger?) lupus, rheumatoid arthritis, Sjogren's, or polymyositis-dermatomyositis.
Other triggers are also becoming apparent.
Thymomas express something very much like acetyl choline receptor, thereby triggering myasthenia gravis (Lancet 339: 707, 1992). Oat cell carcinoma (a lung cancer that simulates nerve cells in several respects) is notorious for exciting autoantibodies against cerebellum, retina, synapse, and/or amygdala. Stay tuned for more of these.
Foreign materials may alter the body enough that it begins attacking itself. Decide for yourself whether breast implants ever cause lupus and scleroderma (I'm unimpressed). But it's generally accepted that there's a link between coal and rock dust exposure and several autoimmune diseases ("Caplan's").
More generally, since the autoimmune diseases exacerbate and remit (until fibrosis / gliosis dominate the picture, of course), it's easy to believe that they result from modulation problems within complex feedback networks.
In Sjogren's, insulin-dependent diabetes, and some other autoimmune diseases of glands, part of the pathogenesis seems to be inappropriate expression of HLA-D (i.e., class II) proteins on the target organ's cells. More about this later. Apoptosis in peripheral lymphocytes is faulty in human lupus, and the mysteries are being unravelled. Br. J. Rheum. 36:158, 1997.
Even more curious, the T-cells of lupus patients evidently attack monocytes and cause them to undergo apoptosis, both providing more antigen and failing to clear apoptotic debris (J. Immunol. 167: 5963, 2001; J. Immunol. 169: 6020, 2002; Arth. Rheum. 46: 191, 2002).
It's hard to study, but I've been able to find nothing at all published recently to support the "pop" notion that emotional stress precipitates autoimmune disease.
* If you are very interested in the molecular basis of the immunogen-toleragen seesaw, check out Lancet 357: 2115, 2001.
Rules that almost always work:
Autoimmune diseases typically are linked to particular Class I (A, B, or C) or Class II (D) HLA antigens, but not both. Those linked to particular class I antigens (i.e., ankylosing spondylitis, Reiter's syndrome, common psoriasis) are more common in men, while those linked to class II antigens (the rest of the autoimmune diseases) show a slight to striking female preponderance. (Type I diabetes favors neither males nor females.) Patients inherit the same HLA antigens as many of their healthy counterparts.
"Because they reflect deviations in complex control networks", the autoimmune diseases are diseases of exacerbations and remissions.
Monozygotic twins of patients are at increased risk, but it is never >30% (i.e., the risk is greatest with juvenile onset diabetes).
Selection of T-cells after antigenic stimulation has been studied in identical twins; if both are sick with a particular T-cell mediated disease, the clones they select tend to be identical; if only one is sick, responses tend to be different. (See Nature 364: 243, 1993.)
Siblings not inheriting the same HLA's that are linked to the immune disease are still at slightly increased risk.
The systemic autoimmune diseases are a family of chronic illnesses of generally unknown etiology. Their older name, "the collagen vascular diseases", is meaningless today. Except for DM-PM and the enthesopathies, all are more common in women.
They include systemic lupus, rheumatoid arthritis, juvenile rheumatoid arthritis, the enthesopathies (probably), scleroderma, DM-PM, Sjogren's syndrome, rheumatic fever, variants of all these, and overlap syndromes. (* We will save some of them for later.)
Each shows some familial tendency but no clear-cut pattern of inheritance.
There is a link between HLA antigens and various autoimmune diseases. The strongest link is between HLA-B27 and spondylitis. * For USMLE I and clerkships, remember B8 (autoimmune diseases of various glands), D2/D3 (lupus), and D4 (rheumatoid arthritis).
Remember that all these diseases are likely to overlap, and that each is probably a syndrome with several possible causes.
"Lupoid chronic-active hepatitis" (several types) and "primary biliary cirrhosis" overlap with this family also, and may be seen with any "systemic autoimmune disease".
The autoimmune diseases all involve abnormal cellular proliferations (lymphocytes in systemic lupus, synovial lining cells in rheumatoid arthritis, fibroblasts in scleroderma and primary biliary cirrhosis, etc.)
Remember also that many apparently healthy people, especially older people, have autoantibodies in relatively high titers.
The most curious new approach to treating autoimmune disease is by feeding the autoantigen.
I am not making this up. The First Americans fed poison ivy to their babies, imparting a tolerance to the rhus hapten. The mechanisms (then and now) include suppression of immunity by TH2 cells, and depletion/anergy of TH1 cells.
Feeding a peptide that mimics myelin basic protein is now a mainstay of the management of multiple sclerosis. Stay tuned for more amazing successes.
* Here are the famous HLA linkages for diseases. This information is not very useful clinically, but has a way of popping up on exams (though not mine).
A3 |
familial hemochromatosis (gene is in this and some other alleles |
B8 & DR3 |
autoimmune Addisonism myasthenia gravis Sjogren's |
B27 |
ankylosing spondylitis Reiter's syndrome enteropathic arthropathy autoimmune uveitis |
B35 |
DeQuervain's |
B38 | psoriatic arthritis |
B51 | Beçet's |
B47 |
21-hydroxylase deficiency (gene is in the allele) |
Cw6 |
common psoriasis |
DR2 |
Goodpasture's multiple sclerosis |
DR3 |
celiac sprue / dermatitis herpetiformis lupoid hepatitis lupus (weak) |
DR3, DR4 |
autoimmune diabetes |
DR4 |
pemphigus rheumatoid arthritis |
DR5 |
autoimmune pernicious anemia Hashimoto's autoimmune thyroiditis |
THE AUTOANTIBODIES (Am. J. Med. 100(2A): 16S, 1996)
The pattern may give you a hint of which antibody is present! (With today's newer tests, these don't work so well as they once did.)
RIM PATTERN | Probably anti-dsDNA. Your patient probably has systemic lupus. |
HOMOGENEOUS PATTERN | Probably anti-histones. Your patient probably has drug-induced lupus. |
SPECKLED PATTERN | Could be anti-Sm and/or anti-Ro/SSA and/or anti-La/SSB and/or anti-U1RNP and/or any of several others. You'll certainly want to continue your workup! |
CENTROMERE PATTERN | An especially fine speckling with little background staining. This is anti-centromere, the marker for CREST / pulmonary hypertension. |
NUCLEOLAR PATTERN | anti-Th or anti-fibrillarin / anti-U3RNP or anti-U17RNP. Think of scleroderma, though most scleroderma patients don't show the nucleolar pattern. |
You can also order these tests for individual autoantibodies.
anti-dsDNA | Anti-double stranded DNA. A misnomer, of course. Your patient has systemic lupus. About half of lupus patients have these antibodies. |
anti-ssDNA | Anti-single stranded DNA. Think of drug-induced lupus. |
anti-histone | Think of drug-induced lupus. |
anti-Sm | Anti-Smith. Your patient has systemic lupus. About a third of lupus patients have these antibodies. |
anti-Ro/SSA | Lupus, Sjogren's, neonatal lupus, or some mix of these. |
anti-La/SSB | Lupus, Sjogren's, or some mix of these |
anti-U1RNP | Anti-ribonucleoprotein. When this is the main autoantibody, your patient has mixed connective tissue disease. |
Anti-Scl70 | Anti-topoisomerase. Your patient has the bad kind of scleroderma. A large minority of people with the bad kind of scleroderma have this autoantibody. |
Anti-centromere | Very sensitive and very specific for CREST, the limited scleroderma variant. |
Anti-Jo | Antibody against transfer-RNA synthetase. Your patient probably has polymyositis / dermatomyositis. About half of PMDM patients have this autoantibody. |
You probably realize that the immune system is a chaotic system, with tiny tweaks able to cause large changes. For example, in lupus there are antibodies that bind antibodies that bind antibodies ("idiotype network": Nat. Med. 10: 17, 2004).
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE, "the red wolf"; NIH review Ann. Int. Med. 123: 42, 1995; Med. Clin. N.A. 81: 113, 1997).
{08403} lupus immune complexes (green) trapped in the glomerulus
{28142} discoid lupus on the face (what features
do you see?)
Lupus is a common, dread, remitting and relapsing illness defined by clinical criteria that you will learn on Internal Medicine. (You can find them in Arthr. Rheumatol. 25: 1271, 1982 or in "Big Robbins".)
Lupus usually manifests as arthritis, skin changes, kidney damage, inflamed serosal membranes, fever, and mental changes. Most lupus victims look healthy, but they are very sick.
Lupus is mostly a disease of young women, though no one is immune; it is slightly more common in blacks. At least one woman in 1000 in the US and worldwide has overt lupus. (* The pediatric disease is essentially the same as the adult form: Pediatrics 83: 325, 1989).
* The biopsychosocial impact of lupus: Arthr. Rheumatol. 27: 13, 1984; J. Rheumatol. 13: 570, 1986. Probably little has changed.
Lupus is a disease of many curious autoantibodies directed against antigens that are common to most or all cells.
The etiology is unknown and surely differs from case to case.
* There is much discussion nowadays, but little hard evidence, of defective clearance of apoptotic cells as "the cause of lupus" (Rheum. Dis. Clin. N.A. 26: 215, 2000; Arth. Rheum. 46: 191, 2002; Arth. Rheum. 48: 2888, 2003). This fits with the photosensitivity (why?), and might explain the lupus-like syndrome in complement component deficiencies (uh, maybe these are required to clear apoptotic bodies). However, excessive numbers or appearances of apoptotic bodies themselves is not seen in lupus under the microscope.
* Alfalfa, which contains L-canavanine, a bizarre amino acid, causes lupus in monkeys and sometimes in humans.
* For the molecular biology of the principal lupus autoantigens, see Arthr. Rheumatol. 29: 457, 1986. These include nucleosomes (by far the most important -- J. Immuno 174: 3326, 2005) and the cytoplasmic Ro antigens; the mechanisms of immune activation appear to be novel for lupus (J. Clin. Invest. 115: 407, 2005).
An environmental agent may contribute. One group claims that dogs belonging to lupus patients are more likely than others to have autoantibodies (Lancet 339: 1378, 1992).
Which autoantibodies are harmful, and how they do their damage, is not always clear.
Most lupus patients make antibodies against their own DNA (mega-review NEJM 338: 1359, 1998). Double-stranded DNA ("native-DNA", * "peripheral" or "rim pattern antibodies") gets trapped in the glomeruli, where it complexes with anti-nDNA (see J. Rheumatol. 13: 512, 1986). The complexes cause damage by a Type III mechanism. (Of course, anti-nuclear antibodies of any sort should be harmless to living cells.)
Other anti-nuclear antibodies are responsible for the "hematoxylin bodies" seen occasionally in tissues, and for the "LE cell phenomenon".
Hematoxylin bodies, pathognomonic of lupus, are altered remnants of nuclei. (* You will not be expected to recognize hematoxylin bodies.)
The LE body is a white blood cell nucleus that has been stripped of its cytoplasm during the phlebotomy, homogenized and opsonized by anti-nuclear antibodies (* typically anti-histone H1: Arth. Rheum. 41: 1446, 1998), and then eaten by a poly or mono. The cell that has eaten the LE body is then called the "LE cell".
{08394} LE cell; Giemsa stained preparation
|
* In one old mouse model for lupus, the autoantibody is directed against a single phosphodiester linkage (which unfortunately for the mice is ubiquitous).
Anti-Ro ("anti-SSA", an autoantibody against an RNA polymerase) crosses the placenta and causes heart block and discoid rash in newborns (probably by a type II immunologic injury). * It also binds to the epidermis, and probably causes some of the photosensitivity.
Antibodies against neurons are thought to cause the psychosis and convulsions often seen in lupus (Type II immunologic injury)
Antibodies against blood cells are known to cause the hemolytic anemia, neutropenia, and thrombocytopenia often seen (together or separately) in lupus (Type II immunologic injury).
Antigen-antibody complexes probably cause most of the arthritis and vasculitis (Type III immunologic injury).
Lupus vasculitis Antibodies to one's own procoagulant activator complex (* Va + X + phospholipid) is the
troublesome "lupus anticoagulant" (an antiphospholipid antibody that inactivates
a freely-floating molecule). This causes paradoxical
deep-vein thrombosis, thrombocytopenia, and abortion. See below.
Antibodies against other clotting factors also can cause trouble.
The histopathology is nonspecific
WebPath photo
Because of the vasculitis (?), lupus patients have accelerated
atherosclerosis (NEJM 349: 2399, 2003).
Lupus patients make many other weird antibodies. (You will learn how and when to test for these sometime.) For example, they tend to develop false-positive syphilis tests (* "biologic false positives", BFP's).
Genetic factors:
* Lupus patients often have HLA-DR2, DR3, A1, and/or B8. The DR2 locus is often linked to a null allele for C4 (there's a mouse model for this now too).
Lupus runs in families, and there's been a great deal of work in the past ten years, mostly people trying to figure out what alleles for what immune molecules ("candidate genes") run with the disease. There's been a lot of data, but no unifying ideas.
Monozygous twins are 25% concordant for lupus, dizygous only 2% (Arth. Rheum. 35: 311, 1992).
Patients with hereditary C2, C4, * C1q (Arth. Rheum. 39: 663, 1996), * C1r, * C1s, * C5, * C7, or * C9 deficiencies get a lupus-like syndrome (Ann. Rheum. Dis. 46: 153, 1987).
The search for a virus in lupus has been unrewarding. * The "myxovirus-like particles" ("tubular arrays") seen in endothelium are a non-specific alpha-interferon effect (Arthr. Rheum. 29: 501, 1986).
Blood vessels:
Lupus vasculitis typically involves the small arteries and arterioles. Type III immune complex injury is usually implicated.
When acute vasculitis is bad, plasma proteins that have gelled in the walls are called "fibrinoid". If the walls are dead, "fibrinoid necrosis" is said to be present.
More chronic vasculitis leads to fibrosis and narrowing of vessels.
A reasonably specific change for lupus vasculitis is concentric adventitial fibrosis ("adventitial onionskinning") around the splenic arteries.
Kidney: ("The kidney is never normal in ANA-positive systemic lupus.")
The glomerulus traps antigens or pre-formed immune complexes as the strainer does in a sink. Several different glomerular syndromes can result.
Lupus glomerulonephritis |
Lupus glomerulonephritis |
Lupus glomerulonephritis In addition, anti-tubular antibodies ("lupus interstitial nephritis") and vasculitis can impair kidney
function.
Skin:
Patients must avoid sunlight. The famous "butterfly rash" results (at least in part) from sunlight on
the malar area of the face.
Butterfly Rash
{08388} butterfly rash
The "discoid rash" is also exacerbated by sun exposure.
Involved areas are sharply demarcated ("discoid"), depigmented (the edges are likely to be
hyperpigmented), hairless, scaly, and shiny. The
microscopic picture shows:
{14316} discoid lupus
Discoid lupus Deposits of immunoglobulins and complement components
("fibrinoid") are found just below the basement
membrane of both involved and uninvolved skin in the majority of lupus patients. These are
detected by the "lupus band test" -- more on this when you see us again, or see
Clin. Exp. Rheum. 17: 427, 1999.
Hives, ulcers, blisters all result from immune injury.
{08385} positive lupus band test (granules
along basement membrane are immune complexes)
Mouth ulcers ("aphthae", little infarcts) are another annoying problem for many lupus patients.
Joints:
Arthritis (inflammation of joint tissues) is common in lupus. It resembles rheumatoid arthritis,
though it is seldom mutilating.
It is probably due to type III immune injury. The histology is acute and chronic synovitis.
"Serositis":
Pleural and pericardial inflammation creates pain and small fibrinous effusions. By autopsy time,
all lupus patients have pleural scarring.
Heart (Mayo Clin. Proc. 74: 275, 1999):
The best-known and most typical change is "nonbacterial verrucous endocarditis" (verrucous means
warty), also called "Libman-Sacks endocarditis".
Many small vegetations occur on all parts of the mitral and tricuspid valves and chordae. They are
made up of necrotic debris with acute and chronic inflammation; they may organize. Usually an
incidental finding at autopsy, they sometimes cause trouble clinically.
Despite old claims to the contrary,
valves do in fact become mutilated in lupus, probably from fibrin
organizing on their surfaces (NEJM 319: 861 & 877, 1988). * There is a strong correlation
between Libman-Sacks and the presence of antiphospholipid antibody (Am. J. Med. 89: 411, 1990).
{06962} Libman-Sacks endocarditis in lupus
Coronary vasculitis occasionally causes sudden death in lupus patients.
In addition, these patients have accelerated coronary artery atherosclerosis for some reason,
independent of the Framingham risk factors.
"Neonatal lupus" is due to maternal anti-Ro(SSA) (* rarely anti-La/SSB or anti-U1-nRNP -- NEJM
316: 1135, 1987). These children have a rash and a serious heart block (anti-Ro attacks their AV
node tissue). Anti-Ro is blamed for some loss of pregnancies,
though evidence is conflicting (Br. J. Rheum. 37: 740, 1998).
(Q. J. Med. 66: 125, 1988).
* Lupus myocarditis is thankfully rarely apparent clinically, but today's
high-powered cardiac investigations are picking up
some subclinical cases (Am. J. Med. 113: 419, 2002).
Blood:
Patients with lupus have increased total serum gamma globulins ("polyclonal gammopathy"; a lab
test result).
Patients with "lupus anticoagulant" tend to have paradoxical thrombosis rather than hemorrhage.
More about this soon. This was a subject for intensive investigation in the late 1980's.
Closely akin to -- but not identical with
-- lupus anticoagulant are anticardiolipin antibodies that cause spontaneous abortion (thrombosis
and infarction of the placenta, or more plausibly, improper implantation Proc. Nat. Acad. Sci. 90:
6464, 1993) & thrombosis and are present in many patients with lupus. Both are related to
false-positive tests for syphilis.
And lupus patients can develop a bleeding tendency due to antibodies against clotting factors
(especially factor VIII), thrombocytopenia, and/or vasculitis.
Or they can just get deep vein thrombosis, without the anticoagulant (Arch. Int. Med. 154: 164,
1994).
* Fulminating lupus hemophagocytic syndrome: Ann. Int. Med. 114: 387, 1991.
Lungs:
Only a few patients get pulmonary lesions directly attributable to lupus (Chest 88: 265, 1985).
* In severe pulmonary lupus, the alveolar walls undergo fibrosis, probably as the result of type III
immune complex injury. In bad cases, the vasculitis causes bleeding into the alveoli (Am. J. Clin.
Path. 85: 552, 1986).
Brain:
Fatigue is a major problem for most lupus patients, and is often the presenting complaint (Arch.
Neurol. 46: 1121, 1989).
Antibodies against neurons probably cause the psychosis and convulsions often seen in lupus.
Brain infarcts (strokes) are a serious problem in many lupus victims.
* In the past, lupus cerebral vasculitis (few inflammatory cells, much intimal proliferation) has
been blamed for most infarcts (strokes) in these patients. It now appears that lupus anti-cardiolipin
antibody is present in most lupus patients with strokes, and the problem may be thrombosis instead
(Am. J. Med. 86: 391, 1989).
NMR studies show evanescent inflammatory lesions and/or generalized atrophy (Arthr. Rheum. 31:
159, 1988; J. Rheumatol. 15: 601, 1988).
Anti-ribosomal P protein antibodies in the blood
and anti-neuronal antibodies in the spinal fluid
have been closely linked to lupus psychosis (but not other CNS
problems): Arth. Rheum. 41: 1819, 1998.
You will learn a great deal about working up lupus in advanced courses and on your internal
medicine rotations.
Most lupus patients have anti-native (i.e., anti-double stranded) DNA, and this antibody is unusual
except in lupus patents. These usually also react with some ribonucleoproteins, which may drive
their production (J. Clin. Invest. 93: 443, 1994).
The few that don't have anti-native DNA will usually have anti-Ro/SSA (not specific for lupus), or
anti-Sm ("Smith" antigen, a nuclear RNP, specific for lupus, though present in only 30%).
Remember that many healthy people have low titers of anti-nuclear antibodies.
Clinical course and treatment:
Lupus still kills people.
Ten percent of patients
presenting with overt lupus are dead from it within five years.
This is usually the result of kidney failure, iatrogenic immunosuppression (infections), bleeding,
heart failure, or brain damage.
After several years, the incidence of myocardial infarction becomes very high in these patients,
probably because of steroid therapy (Am. J. Med. 83: 503, 1987). Iatrogenic disease in lupus
patients: JAMA 263: 1812, 1990.
You will learn about various low-tech (* Omega-3 fish oil) treatments
and high-tech (total lymphoid radiation, pulsed cyclophosphamide, super-high-chemo and
stem-cell rescue Lancet 356: 701, 2000; lots more)
treatments for lupus on rotations.
* Medical history buffs: Queen Anne and lupus. Br. Med. J. 304: 1365, 1992.
Lupus variants:
* Subacute cutaneous lupus erythematosus: Anti-Ro, HLA-DR3, sparing of the kidneys (Med. Clin.
N.A. 73: 1073, 1989). Subclassifying the histopathology for dermatopathologists: Arch. Derm.
130: 54, 1994.
Chronic discoid lupus erythematosus (the usual form of "chronic cutaneous lupus") shows only the
skin changes. It is limited to sun-exposed skin, and immunofluorescence of uninvolved skin is
normal. Around 10% of these patients eventually get the systemic disease, but most
remain ds-DNA-negative and otherwise healthy.
Most drug-induced lupus erythematosus is precipitated by
hydralazine, procainamide, isoniazid, penicillamine, or phenytoin
(* Lovastatin lupus: Arch. Int. Med. 151:
1667, 1991).
The patients have anti-nuclear antibodies just as in lupus. Anti-histone antibodies (* "homogeneous
pattern") are very characteristic, and the ones that actually make a person sick are anti-H2A-H2B
antiguanosine autoantibodies (NEJM 318: 1431 & 1460, 1988).
The drug is of course acting as a hapten. The disease resolves when the drug is withdrawn.
Most of these patients are "slow acetylators"; you'll learn about them in Pharm. * The linkage is
with HLA-DR4.
* Incomplete lupus: patients with suggestive findings but who do not meet the criteria for SLE.
Prognosis is good (Arch. Int. Med. 149: 2473, 1989).
* Canine lupus is an important cause of morbidity in pet dogs ("Millie Bush's disease).
SJOGREN'S SYNDROME (Mikulicz's disease, "autoimmune exocrinopathy", "autoimmune
epithelitis", etc. Review Br. J. Rheum. 35: 204, 1996.
A common, usually mild illness characterized by autoimmune damage to the salivary and lacrimal
glands, plus arthritis.
Sometimes the vulvar and other glands are affected, and occasionally the renal tubules are ruined.
Most patients are middle-aged women. Sjogren's affects perhaps 2 million people in the US.
The terminology is a little loose. This seems to be the common usage:
* "Mikulicz's syndrome" is large salivary and lacrimal glands infiltrated with lymphocytes, from any
cause (Sjogren's, sarcoid, leukemia, lymphoma, AIDS, GVH-disease). Any of these diseases can
cause dryness, and so can many common drugs, notably antihistamines, antipsychotic drugs, and
antidepressants.
"Sicca syndrome" is unexplained dry eyes ("keratoconjunctivitis sicca") and dry mouth
("xerostomia") together.
* "Mikulicz's disease" or "autoimmune exocrinopathy" (neither in common use now) describe "sicca
syndrome" due to autoimmune destruction.
"Primary Sjogren's syndrome" is autoimmune exocrinopathy by itself, or with mild arthritis. Biopsy
of a minor salivary gland (usually from normal-appearing lower lip) is now required for research
subjects.
"Secondary Sjogren's syndrome" is diagnosed when there is associated autoimmune disease:
"Sjogren's with lupus", "Sjogren's with scleroderma", "Sjogren's with polymyositis", or "Sjogren's
with rheumatoid arthritis". Very common -- perhaps a majority of these patients have it: Ann.
Rheum. Dis. 46: 286, 1987.
* "The benign lymphoepithelial lesion" is an anatomic pathologist's description of the glandular
enlargement due to Sjogren's; it may present as a mass.
{35591} Sjogren's histology, minor salivary gland,
fibrosis and lymphocytes
Sjogren's The autoantigens in Sjogren's (primary or secondary)
seems to be alpha-fodrin, a cytoskeleton component found
in the salivary, lacrimal, and bronchial glands and rearranged
when they secrete rapidly (Am. J. Path. 155:
173, 1999; Arch. Derm. 135: 535, 1999, Science 276: 604, 1997)
and the type 3 muscarinic acetylcholine receptor (makes sense; Arth. Rheum. 44:
2376, 2001).
T-cells (mostly helpers; see Semin. Arthr. Rheumatol. 14: 77, 1984) infiltrate and destroy the
glands.
The lymphocytic infiltration is patchy but dense, B-cells enter and germinal follicles may appear,
and the acini and (later) ducts eventually are wrecked.
* The B-cells show abnormalities of their immunoglobulin genes that are characteristic of cancers
rather than benign hyperplasias -- see NEJM 316: 1118, 1987.
The most interesting recent finding is that the epithelial cells in these glands show abnormal
expression of HLA-DR's on their epithelial cells (Hum. Path. 19: 932, 1988). Obviously
something's really scrambled.
* Also intriguing is the development of Sjogren's syndrome both in HTLV-I infection and in HTLV-I
tax transgenic mice (Nature 341: 72, 1989); where Sjogren's is endemic, the prevalence of
antibodies is very high (Lancet 344: 1116, 1994).
Primary or secondary, most Sjogren's patients have autoantibodies of one sort or another.
Almost all female Sjogren's patients have antibodies against two "cytoplasmic" antigens,
anti-Ro/SSA and anti-La/SSB (Ann. Rheum. Dis. 45: 732, 1986; Arthr. Rheum 29: 1223, 1986).
Anti-Ro/SSA is found in many autoimmune diseases (remember it is the cause of neonatal lupus).
* It is especially seen with type III immune-injury vasculitis, which can be devastating (Arthr.
Rheumatol. 28: 1251, 1985; Am. J. Clin. Path. 88: 26, 1987).
Anti-La/SSB is more specific for Sjogren's. (* Anti-RANA, described in Big Robbins, isn't proving
very useful.)
* The histo-compatibility antigens HLA-B8, Dw3, and DRw52 are markers for Sjogren's (Am.
J. Med. 80: 23, 1986).
Manifestations
In "sicca syndrome", patients eventually get damage to the eyes, nasal and oral mucosa from
dryness. Cracker sign: "Would you like to eat a dry cracker right now?" "NO!!" Ask whether the
patient keeps a glass of water at the bedside to sip at night. Do you see lipstick on her front teeth?
The unpleasant, official "dryness test" (* "Schirmer's") involves hanging a strip of filter paper out of
the lower conjunctival sac for fifteen minutes and watching it not wet beyond 1 cm or so. This
sounds like it violates the Geneva convention.
"Sjogren's is an abnormal proliferation of lymphocytes". Patients with diagnosed
primary Sjogren's often
develop B-cell malignant lymphomas (around 10% of primary Sjogren's
patients eventually get lymphoma
(J. Rheum 24: 2376 1998 & many others.)
Oncogenes and chromosomal rearrangements in "benign Sjogren's":
Arth. Rheum. 40: 318, 1998.
* Up to 40% of patients have an interstitial nephritis, and this is occasionally a problem (severe distal
renal tubular acidosis, potassium wasting; Ann. Int. Med. 110: 405, 1989).
* Dr. Sjogren's observation that these patients often develop chronic shortness of breath has
been confirmed -- patients get a lymphocytic bronchiolitis and eventually develop the same
symptoms as old smokers. See Arthr. Rheum. 30: 249, 1987.
SCLERODERMA ("[Progressive] Systemic Sclerosis"):
Lancet 347: 1453, 1996;
still good.
A family of mild-to-miserable, usually slowly-progressive diseases with excessive fibrosis
throughout the body. The skin is always involved; death is due to damage to the kidneys, lungs,
heart, or GI tract. About one person in 4000 has scleroderma (Mayo Clin. Proc. 60: 105, 1985).
The diagnosis of scleroderma is made on physical exam. It has never been a biopsy or lab doctor's
disease.
The etiology and pathogenesis of scleroderma remain obscure.
* You'll hear reports of fibroblasts from these patients making
too much collagen in tissue cultures, various cytokines (notably the newly-discovered
CTGF, "connective tissue growth factor")
causing
excess collagen proliferation in the skin, and downregulation of proteins that
prevent overcollagenization (Am. J. Path. 163: 571, 2003). However, no clear picture
of the pathogenesis of scleroderma has emerged.
Autoimmunity appears to be a factor, as these patients often have autoantibodies.
Human graft-vs.-host disease
resembles scleroderma's skin, lung, and vascular lesions,
and the best animal model uses B- and T-cells from one mouse strain to
attack the tissues of another (Arth. Rheum. 50: 1319, 2004).
Anti-nucleolar antibodies (* don't bother learning their names)
are worth remembering
as they give the "nucleolar" pattern on the old anti-nuclear antibody screening test.
{33248} anti-nuclear antibody preparation in scleroderma, with each of the thousand points of light
a different nucleolus
Anti-topoisomerase (* Scl-86, etc.) is a marker for severe, diffuse disease,
especially with lung involvement;
more about the antibody and what keeps it going Arth. Rheum. 36:
1580, 1993; the epitope recognized determines the severity
Arth. Rheum. 36: 1406, 1993). The
antigen Scl-70, mentioned in Big Robbins, is a breakdown product of anti-topoisomerase.
* This topoisomerase is a DNA-modifying enzyme that seems to work particularly well at the
collagen gene, causing cells to produce too much collagen (Lancet 2: 475, 1988). This idea is
supported by the discovery that the skin-tight mouse, the genetic model for scleroderma, has high
topoisomerase, and if you can get the mouse to make fewer antibodies, it doesn't get so sick (Cell
Immuno 167: 135, 1996). More on the mouse: Am. J. Path. 165:
641, 2004.
Apoptosis of endothelium is seen early in the disease.
* Claims in the mid-1990's that
anti-endothelial antibodies mediated much of the damage
in scleroderma have failed to find confirmation.
More likely, the deadly onionskinning results from a complex interplay
of molecules. Watch for abnormal fibrous responses to endothelial
damage: J. Imm. 174: 5740, 2005.
Anti-centromere antibody in high titer more or less defines the milder CREST syndrome, a
scleroderma variant (see below; Br. J. Derm. 113: 381, 1985; Am. J. Med. 77: 812, 1984).
* Anti-Th/To antibodies correlate with a milder, perhaps distinct, disease
similar to CREST but with less gastrointestinal involvement
(Arth. Rheum. 41: 74, 1998). Stay tuned.
* Anti-fibrillarin antibodies correlate a severe,
probably distinct scleroderma variant (Arth. Rheum. 39: 1151, 1996;
J. Imm. 163: 1066, 1999).
* Antibodies against RNA polymerases I and III (distinct from Ro
and La)
seem to define a separate scleroderma variant that is especially
rough on the kidneys.
(Br. J. Rheum. 37: 15, 1998). Antibodies against RNA polymerase II
tend to occur with anti-topoisomerase I
(Chest 114: 801, 1998). Stay tuned.
* Fetal cells are found in the skin lesions of about half of women
with scleroderma, raising the possibility that it's graft-vs.-host disease
NEJM 338(17):1186, 1998. This is holding up:
Rheumatology 43: 965, 2004. Watch for more on "microchimerism";
no one knows how common it is even in healthy mothers.
In addition, there are vessel abnormalities.
A vasculitis and monocytic infiltrate precedes the fibrosis as it progresses.
Small vessels in many parts of the body show intimal proliferation. The histology is concentric
fibrosis "onionskinning", but involving the intima this time) and/or myxoid proliferation.
{08466} onion-skinning of intima of small artery in scleroderma
Scleroderma
A clinician can detect scleroderma by observing that only a few large capillaries remain in the nail
folds. ("How to": Arch. Derm. 139: 1027, 2003).
Skin and cutaneous vessels (Med. Clin. N.A. 73: 1167, 1989):
Visible skin changes are preceded in almost all cases by Raynaud's phenomenon (fingers blanching
on exposure to cold; the color sequence is white-blue-red), and then by swelling. (Gangrene of the
fingertips is the result of severe Raynaud's.)
The skin eventually becomes tight and firm. This usually begins on the fingers ("sclerodactyly",
"acrosclerosis") and hands.
The dermis becomes increasingly collagenized, the epidermis thins and loses its adnexa ("atrophy"),
and it may progress to immobility.
{14335} scleroderma, hands (notice calcium in knuckles)
The altered dermis may calcify (feel for this in the finger pads).
The calcium binds to
gamma carboxyglutamic acid residues, so one can treat it with
a low dose of coumarin.
Onionskinning of the intima of the digital vessels is present, and probably explains the Raynaud's.
The skin disease may never get farther than the hands, or may cause microstomia, bedsores, etc.
Alimentary tract:
The smooth muscle of the gut, especially the esophagus, is replaced by collagen. "Rubber hose
esophagus" is a serious problem, causing difficulty swallowing, reflux and aspiration of food.
Malabsorption may result from intestinal involvement.
Musculoskeletal system:
There is a mild chronic synovitis, and about 15% of patients get some chronic myositis with elevated
creatine kinase levels, and collagenization and weakness in proximal extremities.
Kidneys:
The classic lesion in the kidneys is intimal proliferation ("onion-skinning") of the interlobular
arteries in the kidneys.
Intimal onionskinning in the kidney is also typical of "malignant high blood pressure", where it is
accompanied by necrosis and thrombosis of the arteries. One third of patients with scleroderma get
high blood pressure due to the kidney changes, and one third of these get frank "malignant high
blood pressure" ("scleroderma hypertensive crisis"). Great pictures:
Am. J. Kid. Dis. 14: 236, 1989.
Lungs:
Scleroderma patients usually get a diffuse interstitial-alveolar fibrosis. This limits the ability to
breathe ("restrictive lung disease") and to get oxygen into the bloodstream ("alveolar-capillary
block", "diffusion barrier").
A few scleroderma patients have severe pulmonary hypertension, with intimal onionskinning of the
pulmonary arteries. This is more common in the CREST syndrome, where perhaps 10% are
affected.
{33274} scleroderma lung; trichrome stain
shows collagen/scar blue
* Scleroderma patients often die during cold weather from chest colds.
* Other organs:
In unusual cases of scleroderma, there are cardiac arrhythmias, cardiomyopathy, polyneuropathy.
Scleroderma variants:
CREST syndrome ("limited cutaneous scleroderma") -- a milder variant of scleroderma,
distinguished by the presence of anti-centromere antibody.
Calcinosis, Raynaud's phenomenon, Esophageal dysfunction, Sclerodactyly, and
Telangiectasias
(groups of dilated vessels in the skin)
Pulmonary hypertension and primary biliary cirrhosis
(J. Derm. 26: 18, 1999) are common in CREST. The kidneys are
usually spared. * For some reason, these people are also prone to
bad periodontal disease.
Morphea is "a form of scleroderma" confined to one area of the skin (Med. Clin. N.A. 73: 1143,
1989). Remember Lyme disease as one known cause of morphea (surprise!) Classic
morphea does not turn into scleroderma and does not require any lab work beyond (probably)
a Lyme check.
{12187} morphea
Morphea (localized scleroderma)
* Localized linear scleroderma ("sabre-cut scleroderma") is rare and follows a dermatome (Ann. Int.
Med. 104: 849, 1986) and may involve the underlying muscle. It's the common form of morphea/scleroderma in children.
* Eosinophilic fasciitis is yet another systemic variant of scleroderma (Med. Clin. N.A. 73: 1157,
1989). One model for this was the L-tryptophan fiasco (NEJM 322: 874, 1990).
* Scleroderma-like changes developed on the hands of vinyl chloride workers, and some cases have
been linked to industrial solvent exposures (J. Occup. Med. 29: 493, 1987) and the Spanish
toxic oil fiasco (an industrial lubricant loaded with fatty-acid anilides was sold door-to-door by crooks
as olive oil). If augmentation mammoplasty is an additional cause, it is vanishingly rare (Ann. Int. Med.
111: 377, 1989; the article that sparked all the lawsuits).
There is at present no highly-effective treatment for scleroderma. Penicillamine is often
administered, which makes sense because it inhibits collagen synthesis. Gamma interferon is the
most promising experimental therapy (Am. J. Med. 87: 273, 1989). Around 50% of scleroderma
patients are alive five years after diagnosis (Arthr. Rheum. 34: 403, 1991); maybe half the time, the disease
gets somewhat better by itself (Arth. Rheum. 44: 2828, 2001).
* Halofuginone is a proposed drug for scleroderma; it prevents laying-down of the very-dense
collagen, but not of normal collagen: J. Inv. Derm. 106: 84, 1996.
Serendipity: Patients given Iloprost for their Raynaud's
report that this greatly helps the skin tightening; perhaps this modulates
the CTFG effect (J. Clin. Invest. 108: 241, 2001)
* Medical history buffs: The most picturesque (and horrifying) Raynaud's syndrome is
ergotism (intoxication with Claviceps purpura fungus from wet rye. Lysergic acid causes LSD-related psychosis as well
as
gangrene of the extremities and "St. Anthony's flame" neuropathy. Mass
outbreaks are memorable and have occurred even in the mid-20th century.
POLYMYOSITIS (including "DERMATOMYOSITIS"; "DM-PM"; Lancet 355: 53, 2000);
Polymyositis is an inflammatory disease that damages skeletal muscle.
Today, along with dermatomyositis and some uncommon similar syndromes,
there's a tendency to call it "idopathic inflammatory myositis".
Groups of muscle cells degenerate, and there is a chronic inflammatory infiltrate in the muscle.
Dermatomyositis is polymyositis plus skin involvement (* rarely, it occurs without polymyositis:
amyopathic dermatomyositis Arch. Derm. 131: 1458, 1996).
Various rashes occur, the characteristic ones being a lupus-like "butterfly rash", "heliotrope eyelids",
and purple bumps on the knuckles (Gottron's sign). Others may mimic seborrhea.
{13120} Gottron's sign
Muscle biopsy in dermatomyositis The etiology and pathogenesis of polymyositis-dermatomyositis are obscure. There is strong
circumstantial evidence that autoimmunity is somehow involved, but you should ignore
any elegant or complete descriptions of its pathogenesis.
Polymyositis and dermatomyositis tend to occur with evidence of any of the other collagen-vascular
diseases, or with rheumatic fever, sarcoidosis or cancer.
Skeletal muscle ground up and injected with Freund's adjuvant is the basis for the induced animal
models. In humans, some lymphocytes seem to be angry with skeletal muscle.
Antisynthetase syndrome, a subcategory of polymyositis, features antibodies against several of t-RNA synthetases (J.
Immunol. 144: 1737, 1990; Clin. Exp. Rheumatol. 8: 259, 1990). Anti-Jo-1
(anti-histidyl-tRNA synthetase) was the first of these antibodies, which are markers for polymyositis
(anti-Jo-1 is very specific: Arth. Rheum. 39: 292, 1996) and also pulmonary fibrosis.
* Suspected triggers include toxoplasmosis, parvoviruses, immunizations, "stress". The drug
D-penicillamine (useful for rheumatoid arthritis and scleroderma) commonly causes DM-PM.
* Simian AIDS features DM-PM in 50% of cases.
* C2-deficient people get a
polymyositis-like syndrome in addition to their lupus.... The idiopathic disease is often associated
with HLA-DR3/B8. Attempts to isolate a virus have failed.
* Dermatomyositis is a very common disease of collie and shelty puppies (Am. J. Path. 123: 465 &
480, 1986).
Whatever the cause(s), the muscle changes on physical exam and biopsy are characteristic.
Polymyositis affects the proximal muscles of the extremities most severely (weak hips and shoulders,
weak neck flexors).
It spares the extra-ocular muscles (making it easy to distinguish from myasthenia gravis).
The muscles are at first sore, tender, swollen (edematous), and weak. (Patients may complain of
"fatigue" instead).
Perivascular and endomysial inflammation, and muscle cell necrosis, are usually present on biopsy
but may be subtle.
The pathologist also looks for decreased muscle cell diameter at the edge of the bundles
(perifascicular atrophy), which is basically diagnostic.
* Guessing from the biopsy whether it's polymyositis or dermatomyositis isn't reliable.
If you must...
Dermatomyositis
{05780} dermatomyositis, histology; note the lymphocytes in this particular case
Childhood dermatomyositis Later, in severe disease, weakness is profound, and the muscles are fibrotic, * there may be
calcifications, etc.
You will learn about the diagnosis of polymyositis-dermatomyositis in clinics.
There are often increased circulating eosinophils, especially in dermatomyositis.
Serum muscle enzymes are greatly increased (check creatine kinase, * aldolase is measured less
often)
* Electromyography and muscle biopsy are also used.
When you suspect dermatomyositis, rule out cancer, especially in older patients,
especially of the ovary. In a
large minority of cases, the disease is the first sign of an internal malignancy (Ann. Int. Med. 134: 1087, 2001;
NEJM 326: 363, 1992).
Polymyositis and dermatomyositis are miserable diseases,
and are difficult to treat even today (Rheum. 44: 83, 2005).
The treatments (glucocorticoids, cytotoxic agents to suppress the immune response) do not work
very well and are dangerous. (See Arthr. Rheumatol. 28: 590, 1985; J. Rheumatol. 12: 283, 1985).
* Inclusion body myositis is a mild disease, usually involving older men's grip muscles. Despite "Big
Robbins", it is NOT an immune disease. More about it soon.
MIXED CONNECTIVE TISSUE DISEASE (MCTD, "anti-U1-RNP disease")
A mixed picture with features of lupus, polymyositis, and scleroderma. Patients have severe
Raynaud's phenomenon, swollen fingers, mild myositis, and severe joint pain. The rest of the "mix"
is more variable.
The kidneys are spared, and response to steroids is good.
High titers of antibodies against ribonucleoprotein (U1-RNP, one of the "speckled pattern"
antibodies) are characteristic.
Many rheumatologists challenge the status of MCTD and/or CREST
as distinct diseases.
Regardless, when U1RNP titers are high,
the patient will likely have arthritis / myositis (Br.
J. Rheum. 37: 39, 1998).
Anti-nuclear antibodies
* FIBROMYALGIA SYNDROME ("allodynia",
"fibrositis", "rheumatic pain modulation disorder";
"muscular rheumatism", not an autoimmune disease
Scand. J. Rheum. S94: 1-70, 1992 (huge);
Br. Med. J. 310: 386, 1995; Am. Fam. Phys. 53: 1698, 1996; Postgrad. Med. 100(1):
153, July 1996; Am. J. Med. Sci. June 1998.
Fibrositis is the most common diagnosis made by consulting rheumatologists today. This is an
extremely common, distinct disease without any known anatomic or laboratory correlates. (Just like
today's oh-so-organic migraine was in the pre-1990's era, remember?
It is a mysterious pain syndrome with morning stiffness,
deep tenderness at predictable locations ("trigger points" -- to learn where and how to poke, see
Arthr. Rheum. 31: 182, 1988). Patients are often disabled. There are EEG abnormalities in deep
sleep, and probably some kind of disturbance in brain serotonin metabolism. By now,
it's clear that there is
a central problem with pain modulation ("nociception") in these patients: Arth. Rheum.
36: 642, 1993; Arth. Rheum. 40: 98, 1997.
Typical victims are young, effective women who dislike alcohol and Valium, and complain of
nonrestorative sleep. Treating fibrositis is complex; aerobic exercise is important (swimming, being non-impact,
is often helpful), and certain drugs
seem to help (try cyclobenzoprine 10 mg q HS, helps a large minority of patients. or nowadays
the newer antidepressants). Acupuncture at
the trigger points has been reported as useful, as is injection of anesthetics.
Acupuncture gets a "definite maybe" from the Maryland Complementary Medicine Program:
J. Fam. Pract. 48: 213, 1999.
There may be as many
as 6 million patients with this illness in the U.S. I remember these patients being ridiculed (in the
1970's) as "total body pain" cases -- malingerers or neurotics. (Presently the "personality problems"
of these patients are attributed to chronic pain.) Fibromyalgia syndrome is not presently considered
to be an autoimmune disease. (This pathologist questions the experience of clinicians who have
published photos of "positive lupus band tests" from these patients -- they look like classic negative
studies. See RDCNA above.) Not everyone believes in fibromyalgia: Br. Med. J. 303: 216, 1991 (I
couldn't follow this guy's logic). The 1992 Copenhagen Conference declared this to be a real entity
(Lancet 340: 1103, 1992) and attempts a better definition.
Get out the tricyclics (Arch. Int. Med. 156: 1047, 1996; Arth. Rheum. 39: 1852, 1996; J. Fam.
Pract. 44: 128, 1997). In 1987, I predicted the selective serotonin uptake inhibitors would be
successful in treating fibromyalgia, and this has now been nicely confirmed.
Guifenesin, a current "pop" remedy, has a devoted
following among self-help groups, and the drug
seems to have some poorly-understood muscle-relaxant and analgesic
properties (JABFP 17: 240, 2004; some obscure journals).
Stay tuned.
* Lab workups for all the rheumatic diseases: Am. J. Med. 100(2S): 16-S, 1996.
* Reminder: You will study osteoarthritis ("wear and tear arthritis"), rheumatoid arthritis, the
enthesopathies, and rheumatic fever later in the course. Another important cause of multi-joint
arthritis is iron overload -- fairly common, and very preventable.
Lots of immune complexes
WebPath photo
Patient photo
Brazilian Medical Students
{12273} butterfly rash
{12274} butterfly rash
{25551} butterfly rash
{33208} lupus butterfly
{08376} discoid rash of lupus, histology (nice
local hydropic change in basal layer)
{11985} discoid lupus
{28868} discoid lupus
{28877} discoid lupus (good plugs)
{28880} discoid lupus (good atrophy / hyperkeratosis
of epidermis)
WebPath photo
* The old claim that the lupus band test on non-sun-exposed skin
being positive in systemic lupus and negative in discoid lupus is discredited.
* Future dermatologists: Try topical tacrolimus (Rheumatology
43: 1383, 2004).
{33205} positive lupus band test, better example
* Current work looks at the presence of apoptotic endothelial
cells as a marker for coronary disease and abnormal vascular tone, and
an explanation for the vascular lesions generally.
Stay tuned. Blood 103: 3677, 2004.
* This autoantibody is also common in people who do not have lupus,
and if it is the presenting problem, the vast majority of patients
do not develop systemic lupus (Medicine 84: 225, 2005).
* Molecular biology of Smith, which has some distinctive epitopes: J. Immuno. 167: 562, 2001.
{35594} Sjogren's histology
{35597} Sjogren's histology; note lots and lots of lymphocytes
Histopathology
WebPath photo
{08469} intimal proliferation in scleroderma (elastic
stain, kidney)
{24854} intimal proliferation in scleroderma demonstrated with PAS stain
{33259} intimal proliferation in small artery of the scleroderma kidney;
the tubules are atrophic because of the longstanding lack of blood flow
{17124} kidney vascular changes in scleroderma
Note the sclerodactyly and facial changes
WebPath photo
Scleroderma Kidney
AJKD
Great pictures
{14336} scleroderma, finger (notice that the
thin epidermis makes the skin shiny, and that the vessels are bunched
at the nail root)
{25460} scleroderma, acrosclerosis
{24626} scleroderma, hands
{24917} scleroderma, histology of skin
{08460} scleroderma, histology of skin
* Future pathologists: The localized scleroderma variants feature
inflammation and fibrosis of the papillary dermis; this is spared in regular
scleroderma.
{14333} morphea
{15358} morphea
Prize photograph
Institute of Medical Illustrators
{14342} heliotrope eyelids
{14338} Gottron's sign (easier
to see on the left hand than on the right hand)
{14339} Gottron's sign
{14340} Gottron's sign
{15346} butterfly rash (closely resembles lupus)
Text and photomicrographs
Dr. Warnock's Collection
Polymyositis
{05789} dermatomyositis, late, trichrome stain; muscle cells
(red) are
largely replaced by scar tissue (blue)
{09039} polymyositis, histology in muscle; note lymphocytes
{14358} polymyositis, histology; good perifascicular atrophy
{29501} polymyositis; find a few
examples each of muscle fibers undergoing
necrosis, atrophy, and regeneration
Wash U, St. Louis
Nucleolar pattern
WebPath photo
Visitors to www.pathguy.com reset Jan. 30, 2005: |
Ed says, "This world would be a sorry place if
people like me who call ourselves Christians
didn't try to act as good as
other
good people
."
Prayer Request
Teaching Pathology
PathMax -- Shawn E. Cowper MD's
pathology education links
Ed's Autopsy Page
Notes for Good Lecturers
Small Group Teaching
Socratic
Teaching
Preventing "F"'s
Classroom Control
"I Hate Histology!"
Ed's Physiology Challenge
Pathology Identification
Keys ("Kansas City Field Guide to Pathology")
Ed's Basic Science
Trivia Quiz -- have a chuckle!
Rudolf
Virchow on Pathology Education -- humor
Curriculum Position Paper -- humor
The Pathology Blues
Ed's Pathology Review for USMLE I
Pathological Chess |
Taser Video 83.4 MB 7:26 min |